25 XP   0   0   10

Keymed Biosciences Inc
Buy, Hold or Sell?

Let's analyse Keymed Biosciences Inc together

PenkeI guess you are interested in Keymed Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Keymed Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Keymed Biosciences Inc

I send you an email if I find something interesting about Keymed Biosciences Inc.

Quick analysis of Keymed Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Keymed Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
HK$13.01
Expected worth in 1 year
HK$8.65
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
HK$-4.36
Return On Investment
-13.5%

For what price can you sell your share?

Current Price per Share
HK$32.30
Expected price per share
HK$21.10 - HK$43.50
How sure are you?
50%

1. Valuation of Keymed Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

HK$32.30

Intrinsic Value Per Share

HK$-37.93 - HK$-45.39

Total Value Per Share

HK$-24.92 - HK$-32.38

2. Growth of Keymed Biosciences Inc (5 min.)




Is Keymed Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$460.8m$503.7m-$42.8m-9.3%

How much money is Keymed Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$42.5m-$536.3m$493.8m1,161.6%
Net Profit Margin-307.9%-3,525.3%--

How much money comes from the company's main activities?

3. Financial Health of Keymed Biosciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#122 / 1010

Most Revenue
#266 / 1010

Most Profit
#866 / 1010

Most Efficient
#683 / 1010

What can you expect buying and holding a share of Keymed Biosciences Inc? (5 min.)

Welcome investor! Keymed Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Keymed Biosciences Inc.

What can you expect buying and holding a share of Keymed Biosciences Inc?

First you should know what it really means to hold a share of Keymed Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Keymed Biosciences Inc is HK$32.30. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Keymed Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Keymed Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$13.01. Based on the TTM, the Book Value Change Per Share is HK$-1.09 per quarter. Based on the YOY, the Book Value Change Per Share is HK$18.38 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Keymed Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps-0.15-0.5%-0.15-0.5%-1.92-5.9%-0.64-2.0%-0.64-2.0%
Usd Book Value Change Per Share-0.14-0.4%-0.14-0.4%2.357.3%0.421.3%0.421.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.14-0.4%-0.14-0.4%2.357.3%0.421.3%0.421.3%
Usd Price Per Share6.51-6.51-4.38-2.72-2.72-
Price to Earnings Ratio-42.50--42.50--2.28--11.20--11.20-
Price-to-Total Gains Ratio-46.76--46.76-1.87--22.45--22.45-
Price to Book Ratio3.92-3.92-2.43-1.59-1.59-
Price-to-Total Gains Ratio-46.76--46.76-1.87--22.45--22.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.12471
Number of shares242
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.140.42
Usd Total Gains Per Share-0.140.42
Gains per Quarter (242 shares)-33.70100.51
Gains per Year (242 shares)-134.82402.06
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-135-1450402392
20-270-2800804794
30-404-415012061196
40-539-550016081598
50-674-685020102000
60-809-820024122402
70-944-955028142804
80-1079-1090032163206
90-1213-1225036193608
100-1348-1360040214010

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.04.00.00.0%0.04.00.00.0%0.04.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.04.00.0%0.00.04.00.0%0.00.04.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.03.00.025.0%1.03.00.025.0%1.03.00.025.0%

Fundamentals of Keymed Biosciences Inc

About Keymed Biosciences Inc

Keymed Biosciences Inc., a biotechnology company, engages in the research and development of biological therapies for the treatment of autoimmunity and oncology diseases. Its lead product candidate is CM310 for the treatment of moderate to severe atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), and chronic obstructive pulmonary disease (COPD). The company is also developing CM326, a monoclonal antibody targeting thymic stromal lymphopoietin to treat moderate-to severe AD, CRSwNP, asthma, and COPD. In addition, it develops CMG901 for the treatment of solid tumors, and gastric and gastroesophageal cancers; and CM313, a humanized monoclonal antibody to treat relapsed or refractory multiple myeloma, lymphoma and other hematological malignancies, and systemic lupus erythematosus. Further, the company is developing CM338, an antagonist antibody against mannose-binding lectinassociated serine protease-2; CM355 for the treatment of relapsed or refractory non-Hodgkin's lymphoma; CM336 to treat multiple myeloma; CM350 for the treatment of solid tumors; and CM369, an anti-CC chemokine receptor 8 monoclonal antibody. Keymed Biosciences Inc. was formerly known as 2Health Biosciences, Inc. The company was founded in 2016 and is headquartered in Chengdu, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-16 09:26:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Keymed Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Keymed Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Keymed Biosciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -307.9% means that $-3.08 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Keymed Biosciences Inc:

  • The MRQ is -307.9%. The company is making a huge loss. -2
  • The TTM is -307.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-307.9%TTM-307.9%0.0%
TTM-307.9%YOY-3,525.3%+3,217.4%
TTM-307.9%5Y-958.3%+650.4%
5Y-958.3%10Y-958.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-307.9%-200.1%-107.8%
TTM-307.9%-216.8%-91.1%
YOY-3,525.3%-288.3%-3,237.0%
5Y-958.3%-449.1%-509.2%
10Y-958.3%-605.5%-352.8%
1.1.2. Return on Assets

Shows how efficient Keymed Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Keymed Biosciences Inc to the Biotechnology industry mean.
  • -7.8% Return on Assets means that Keymed Biosciences Inc generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Keymed Biosciences Inc:

  • The MRQ is -7.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.8%TTM-7.8%0.0%
TTM-7.8%YOY-98.8%+91.0%
TTM-7.8%5Y-71.6%+63.8%
5Y-71.6%10Y-71.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.8%-13.3%+5.5%
TTM-7.8%-12.8%+5.0%
YOY-98.8%-11.7%-87.1%
5Y-71.6%-13.9%-57.7%
10Y-71.6%-15.7%-55.9%
1.1.3. Return on Equity

Shows how efficient Keymed Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Keymed Biosciences Inc to the Biotechnology industry mean.
  • -9.2% Return on Equity means Keymed Biosciences Inc generated $-0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Keymed Biosciences Inc:

  • The MRQ is -9.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.2%TTM-9.2%0.0%
TTM-9.2%YOY-106.5%+97.2%
TTM-9.2%5Y-28.9%+19.7%
5Y-28.9%10Y-28.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.2%-16.9%+7.7%
TTM-9.2%-16.1%+6.9%
YOY-106.5%-15.1%-91.4%
5Y-28.9%-19.3%-9.6%
10Y-28.9%-20.2%-8.7%

1.2. Operating Efficiency of Keymed Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Keymed Biosciences Inc is operating .

  • Measures how much profit Keymed Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Keymed Biosciences Inc to the Biotechnology industry mean.
  • An Operating Margin of -544.1% means the company generated $-5.44  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Keymed Biosciences Inc:

  • The MRQ is -544.1%. The company is operating very inefficient. -2
  • The TTM is -544.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-544.1%TTM-544.1%0.0%
TTM-544.1%YOY-324.2%-219.9%
TTM-544.1%5Y-217.1%-327.1%
5Y-217.1%10Y-217.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-544.1%-296.2%-247.9%
TTM-544.1%-232.5%-311.6%
YOY-324.2%-298.2%-26.0%
5Y-217.1%-492.1%+275.0%
10Y-217.1%-632.4%+415.3%
1.2.2. Operating Ratio

Measures how efficient Keymed Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 5.81 means that the operating costs are $5.81 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Keymed Biosciences Inc:

  • The MRQ is 5.805. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.805. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.805TTM5.8050.000
TTM5.805YOY4.523+1.282
TTM5.8055Y2.582+3.223
5Y2.58210Y2.5820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.8053.231+2.574
TTM5.8053.310+2.495
YOY4.5233.890+0.633
5Y2.5825.739-3.157
10Y2.5827.876-5.294

1.3. Liquidity of Keymed Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Keymed Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.72 means the company has $8.72 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Keymed Biosciences Inc:

  • The MRQ is 8.717. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.717. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.717TTM8.7170.000
TTM8.717YOY31.960-23.243
TTM8.7175Y13.167-4.449
5Y13.16710Y13.1670.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.7173.890+4.827
TTM8.7174.173+4.544
YOY31.9605.344+26.616
5Y13.1676.126+7.041
10Y13.1676.448+6.719
1.3.2. Quick Ratio

Measures if Keymed Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Keymed Biosciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 15.13 means the company can pay off $15.13 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Keymed Biosciences Inc:

  • The MRQ is 15.135. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 15.135. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ15.135TTM15.1350.000
TTM15.135YOY49.429-34.295
TTM15.1355Y19.707-4.572
5Y19.70710Y19.7070.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.1353.514+11.621
TTM15.1353.998+11.137
YOY49.4295.380+44.049
5Y19.7076.105+13.602
10Y19.7076.404+13.303

1.4. Solvency of Keymed Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Keymed Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Keymed Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.15 means that Keymed Biosciences Inc assets are financed with 15.1% credit (debt) and the remaining percentage (100% - 15.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Keymed Biosciences Inc:

  • The MRQ is 0.151. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.151. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.151TTM0.1510.000
TTM0.151YOY0.072+0.079
TTM0.1515Y1.177-1.026
5Y1.17710Y1.1770.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1510.339-0.188
TTM0.1510.336-0.185
YOY0.0720.271-0.199
5Y1.1770.366+0.811
10Y1.1770.389+0.788
1.4.2. Debt to Equity Ratio

Measures if Keymed Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Keymed Biosciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 17.7% means that company has $0.18 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Keymed Biosciences Inc:

  • The MRQ is 0.177. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.177. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.177TTM0.1770.000
TTM0.177YOY0.078+0.100
TTM0.1775Y0.064+0.114
5Y0.06410Y0.0640.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1770.388-0.211
TTM0.1770.402-0.225
YOY0.0780.335-0.257
5Y0.0640.426-0.362
10Y0.0640.461-0.397

2. Market Valuation of Keymed Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Keymed Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Keymed Biosciences Inc to the Biotechnology industry mean.
  • A PE ratio of -42.50 means the investor is paying $-42.50 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Keymed Biosciences Inc:

  • The EOD is -26.915. Based on the earnings, the company is expensive. -2
  • The MRQ is -42.497. Based on the earnings, the company is expensive. -2
  • The TTM is -42.497. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-26.915MRQ-42.497+15.582
MRQ-42.497TTM-42.4970.000
TTM-42.497YOY-2.285-40.212
TTM-42.4975Y-11.195-31.302
5Y-11.19510Y-11.1950.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-26.915-2.264-24.651
MRQ-42.497-2.629-39.868
TTM-42.497-2.680-39.817
YOY-2.285-4.145+1.860
5Y-11.195-6.257-4.938
10Y-11.195-6.254-4.941
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Keymed Biosciences Inc:

  • The EOD is -12.169. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -19.214. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -19.214. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.169MRQ-19.214+7.045
MRQ-19.214TTM-19.2140.000
TTM-19.214YOY-22.919+3.705
TTM-19.2145Y-10.533-8.681
5Y-10.53310Y-10.5330.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-12.169-2.973-9.196
MRQ-19.214-3.333-15.881
TTM-19.214-3.553-15.661
YOY-22.919-5.605-17.314
5Y-10.533-8.376-2.157
10Y-10.533-8.865-1.668
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Keymed Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.92 means the investor is paying $3.92 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Keymed Biosciences Inc:

  • The EOD is 2.483. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.920. Based on the equity, the company is fair priced.
  • The TTM is 3.920. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.483MRQ3.920-1.437
MRQ3.920TTM3.9200.000
TTM3.920YOY2.432+1.488
TTM3.9205Y1.588+2.332
5Y1.58810Y1.5880.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.4831.896+0.587
MRQ3.9202.115+1.805
TTM3.9202.093+1.827
YOY2.4322.884-0.452
5Y1.5883.542-1.954
10Y1.5883.916-2.328
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Keymed Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.091-1.0910%18.376-106%3.253-134%3.253-134%
Book Value Per Share--13.01013.0100%14.101-8%5.440+139%5.440+139%
Current Ratio--8.7178.7170%31.960-73%13.167-34%13.167-34%
Debt To Asset Ratio--0.1510.1510%0.072+109%1.177-87%1.177-87%
Debt To Equity Ratio--0.1770.1770%0.078+128%0.064+178%0.064+178%
Dividend Per Share----0%-0%-0%-0%
Eps---1.200-1.2000%-15.014+1151%-5.016+318%-5.016+318%
Free Cash Flow Per Share---2.654-2.6540%-1.497-44%-1.301-51%-1.301-51%
Free Cash Flow To Equity Per Share---2.686-2.6860%12.556-121%2.704-199%2.704-199%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---45.395--------
Intrinsic Value_10Y_min---37.934--------
Intrinsic Value_1Y_max---2.213--------
Intrinsic Value_1Y_min---2.151--------
Intrinsic Value_3Y_max---8.430--------
Intrinsic Value_3Y_min---7.930--------
Intrinsic Value_5Y_max---16.793--------
Intrinsic Value_5Y_min---15.273--------
Market Cap8937280800.000-58%14146689570.00014146689570.0000%9594929913.800+47%5935404870.950+138%5935404870.950+138%
Net Profit Margin---3.079-3.0790%-35.253+1045%-9.583+211%-9.583+211%
Operating Margin---5.441-5.4410%-3.242-40%-2.171-60%-2.171-60%
Operating Ratio--5.8055.8050%4.523+28%2.582+125%2.582+125%
Pb Ratio2.483-58%3.9203.9200%2.432+61%1.588+147%1.588+147%
Pe Ratio-26.915+37%-42.497-42.4970%-2.285-95%-11.195-74%-11.195-74%
Price Per Share32.300-58%51.00051.0000%34.300+49%21.325+139%21.325+139%
Price To Free Cash Flow Ratio-12.169+37%-19.214-19.2140%-22.919+19%-10.533-45%-10.533-45%
Price To Total Gains Ratio-29.615+37%-46.761-46.7610%1.867-2605%-22.447-52%-22.447-52%
Quick Ratio--15.13515.1350%49.429-69%19.707-23%19.707-23%
Return On Assets---0.078-0.0780%-0.988+1161%-0.716+814%-0.716+814%
Return On Equity---0.092-0.0920%-1.065+1054%-0.289+214%-0.289+214%
Total Gains Per Share---1.091-1.0910%18.376-106%3.253-134%3.253-134%
Usd Book Value--460849781.719460849781.7190%503713670.068-9%193860993.285+138%193860993.285+138%
Usd Book Value Change Per Share---0.139-0.1390%2.347-106%0.415-134%0.415-134%
Usd Book Value Per Share--1.6611.6610%1.801-8%0.695+139%0.695+139%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.153-0.1530%-1.917+1151%-0.641+318%-0.641+318%
Usd Free Cash Flow---94022219.580-94022219.5800%-53461553.665-43%-46181582.721-51%-46181582.721-51%
Usd Free Cash Flow Per Share---0.339-0.3390%-0.191-44%-0.166-51%-0.166-51%
Usd Free Cash Flow To Equity Per Share---0.343-0.3430%1.603-121%0.345-199%0.345-199%
Usd Market Cap1141290758.160-58%1806532258.0891806532258.0890%1225272549.992+47%757951202.020+138%757951202.020+138%
Usd Price Per Share4.125-58%6.5136.5130%4.380+49%2.723+139%2.723+139%
Usd Profit---42509726.854-42509726.8540%-536320671.788+1162%-178719761.599+320%-178719761.599+320%
Usd Revenue--13805399.92613805399.9260%15213491.945-9%7254722.968+90%7254722.968+90%
Usd Total Gains Per Share---0.139-0.1390%2.347-106%0.415-134%0.415-134%
 EOD+3 -5MRQTTM+0 -0YOY+10 -235Y+16 -1710Y+16 -17

3.2. Fundamental Score

Let's check the fundamental score of Keymed Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-26.915
Price to Book Ratio (EOD)Between0-12.483
Net Profit Margin (MRQ)Greater than0-3.079
Operating Margin (MRQ)Greater than0-5.441
Quick Ratio (MRQ)Greater than115.135
Current Ratio (MRQ)Greater than18.717
Debt to Asset Ratio (MRQ)Less than10.151
Debt to Equity Ratio (MRQ)Less than10.177
Return on Equity (MRQ)Greater than0.15-0.092
Return on Assets (MRQ)Greater than0.05-0.078
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Keymed Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.771
Ma 20Greater thanMa 5031.395
Ma 50Greater thanMa 10033.078
Ma 100Greater thanMa 20038.526
OpenGreater thanClose29.950
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,932,316
Total Liabilities592,028
Total Stockholder Equity3,340,288
 As reported
Total Liabilities 592,028
Total Stockholder Equity+ 3,340,288
Total Assets = 3,932,316

Assets

Total Assets3,932,316
Total Current Assets3,309,974
Long-term Assets622,342
Total Current Assets
Cash And Cash Equivalents 588,050
Short-term Investments 2,571,256
Inventory 44,495
Other Current Assets 2,253
Total Current Assets  (as reported)3,309,974
Total Current Assets  (calculated)3,206,054
+/- 103,920
Long-term Assets
Property Plant Equipment 596,465
Intangible Assets 1,496
Other Assets 15,841
Long-term Assets  (as reported)622,342
Long-term Assets  (calculated)613,802
+/- 8,540

Liabilities & Shareholders' Equity

Total Current Liabilities379,699
Long-term Liabilities213,399
Total Stockholder Equity3,340,288
Total Current Liabilities
Short Long Term Debt 61,163
Accounts payable 14,913
Total Current Liabilities  (as reported)379,699
Total Current Liabilities  (calculated)76,076
+/- 303,623
Long-term Liabilities
Long term Debt Total 49,728
Other Liabilities 163,671
Long-term Liabilities  (as reported)213,399
Long-term Liabilities  (calculated)213,399
+/-0
Total Stockholder Equity
Common Stock170
Retained Earnings -5,290,006
Capital Surplus 8,485,153
Total Stockholder Equity (as reported)3,340,288
Total Stockholder Equity (calculated)3,195,317
+/- 144,971
Other
Capital Stock170
Cash And Equivalents16,020
Cash and Short Term Investments 3,175,326
Common Stock Shares Outstanding 277,386
Liabilities and Stockholders Equity 3,932,316
Net Invested Capital 3,430,251
Net Tangible Assets 3,338,792
Net Working Capital 2,930,275
Property Plant and Equipment Gross 653,677



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-31
> Total Assets 
658,578
529,945
3,934,455
3,932,316
3,932,3163,934,455529,945658,578
   > Total Current Assets 
518,405
380,917
3,581,949
3,309,974
3,309,9743,581,949380,917518,405
       Cash And Cash Equivalents 
432,608
199,409
1,520,619
588,050
588,0501,520,619199,409432,608
       Short-term Investments 
66,341
154,673
2,003,960
2,571,256
2,571,2562,003,960154,67366,341
       Net Receivables 
1,165
842
11,270
0
011,2708421,165
       Inventory 
3,306
6,846
22,426
44,495
44,49522,4266,8463,306
       Other Current Assets 
1,648
1,881
7,404
2,253
2,2537,4041,8811,648
   > Long-term Assets 
140,173
149,028
352,506
622,342
622,342352,506149,028140,173
       Property Plant Equipment 
128,940
126,147
306,481
596,465
596,465306,481126,147128,940
       Intangible Assets 
38
109
1,104
1,496
1,4961,10410938
       Other Assets 
14,806
24,104
153,591
15,841
15,841153,59124,10414,806
> Total Liabilities 
934,533
1,624,748
283,485
592,028
592,028283,4851,624,748934,533
   > Total Current Liabilities 
71,590
80,240
112,075
379,699
379,699112,07580,24071,590
       Short-term Debt 
10,747
10,985
0
0
0010,98510,747
       Short Long Term Debt 
47,747
42,373
553
61,163
61,16355342,37347,747
       Accounts payable 
3,478
3,418
2,784
14,913
14,9132,7843,4183,478
       Other Current Liabilities 
9,338
14,961
47,086
0
047,08614,9619,338
   > Long-term Liabilities 
862,943
1,544,508
176,998
213,399
213,399176,9981,544,508862,943
       Long term Debt Total 
128,093
151,950
168,279
49,728
49,728168,279151,950128,093
       Long term Debt 
103,822
131,636
141,294
28,800
28,800141,294131,636103,822
       Capital Lease Obligations 
28,701
24,492
38,709
32,006
32,00638,70924,49228,701
       Other Liabilities 
105,409
138,422
150,013
163,671
163,671150,013138,422105,409
> Total Stockholder Equity
-275,955
-1,094,538
3,650,970
3,340,288
3,340,2883,650,970-1,094,538-275,955
   Common Stock
45
45
171
170
1701714545
   Retained Earnings 
-276,000
-1,094,583
3,650,799
-5,290,006
-5,290,0063,650,799-1,094,583-276,000
   Capital Surplus 
0
0
8,515,868
8,485,153
8,485,1538,515,86800
   Treasury Stock0000
   Other Stockholders Equity 0000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue100,063
Cost of Revenue-2,585
Gross Profit97,47897,478
 
Operating Income (+$)
Gross Profit97,478
Operating Expense-578,327
Operating Income-285,489-480,849
 
Operating Expense (+$)
Research Development507,374
Selling General Administrative133,912
Selling And Marketing Expenses-
Operating Expense578,327641,286
 
Net Interest Income (+$)
Interest Income17,930
Interest Expense-193,346
Other Finance Cost-221,335
Net Interest Income45,919
 
Pretax Income (+$)
Operating Income-285,489
Net Interest Income45,919
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-303,597-285,489
EBIT - interestExpense = -737,837
-308,115
-114,769
Interest Expense193,346
Earnings Before Interest and Taxes (EBIT)-544,491-110,251
Earnings Before Interest and Taxes (EBITDA)-259,255
 
After tax Income (+$)
Income Before Tax-303,597
Tax Provision-0
Net Income From Continuing Ops-303,597-303,597
Net Income-308,115
Net Income Applicable To Common Shares-308,115
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses683
Total Other Income/Expenses Net--45,919
 

Technical Analysis of Keymed Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Keymed Biosciences Inc. The general trend of Keymed Biosciences Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Keymed Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Keymed Biosciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 33.85 < 40.00 < 43.50.

The bearish price targets are: 27.40 > 24.50 > 21.10.

Tweet this
Keymed Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Keymed Biosciences Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Keymed Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Keymed Biosciences Inc. The current macd is -1.18790666.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Keymed Biosciences Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Keymed Biosciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Keymed Biosciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Keymed Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartKeymed Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Keymed Biosciences Inc. The current adx is 14.38.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Keymed Biosciences Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Keymed Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Keymed Biosciences Inc. The current sar is 26.60.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Keymed Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Keymed Biosciences Inc. The current rsi is 50.77. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Keymed Biosciences Inc Daily Relative Strength Index (RSI) ChartKeymed Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Keymed Biosciences Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Keymed Biosciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Keymed Biosciences Inc Daily Stochastic Oscillator ChartKeymed Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Keymed Biosciences Inc. The current cci is 15.76.

Keymed Biosciences Inc Daily Commodity Channel Index (CCI) ChartKeymed Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Keymed Biosciences Inc. The current cmo is 9.83099308.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Keymed Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartKeymed Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Keymed Biosciences Inc. The current willr is -21.37931034.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Keymed Biosciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Keymed Biosciences Inc Daily Williams %R ChartKeymed Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Keymed Biosciences Inc.

Keymed Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Keymed Biosciences Inc. The current atr is 2.54409091.

Keymed Biosciences Inc Daily Average True Range (ATR) ChartKeymed Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Keymed Biosciences Inc. The current obv is -45,062,323.

Keymed Biosciences Inc Daily On-Balance Volume (OBV) ChartKeymed Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Keymed Biosciences Inc. The current mfi is 43.47.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Keymed Biosciences Inc Daily Money Flow Index (MFI) ChartKeymed Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Keymed Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Keymed Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Keymed Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.771
Ma 20Greater thanMa 5031.395
Ma 50Greater thanMa 10033.078
Ma 100Greater thanMa 20038.526
OpenGreater thanClose29.950
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Keymed Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Keymed Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Keymed Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Keymed Biosciences Inc

I send you an email if I find something interesting about Keymed Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Keymed Biosciences Inc.

Receive notifications about Keymed Biosciences Inc in your mailbox!